Hey everybody, Bubba here. Wrestling season is upon us and I bring exciting news! In an effort to improve our coverage to something more befitting the best wrestling program in the nation, we have ...

ARTERY Technology, in collaboration with its Korean distributor IGM, held the 2025 ARTERY WORKSHOP – AT32 IDE & Work Bench ...

First presentation of U.S. IDE clinical data shows statistically significant improvements in pain and function at 24 months compared with fusion surgery BEVERLY HILLS, CA / ACCESS Newswire / November ...

Get the latest on Pulse Biosciences’ Q3 2025 earnings: commercial growth, FDA progress, and clinical trial updates in soft tissue and cardiac therapies.

CorrectSequence Therapeutics' CS-121 Completed Dosing of First Chylomicronemia Patient, Demonstrating Excellent Safety and ...

First-of-its-kind study represents the potential for robotic-enabled microsurgical intervention for neurodegenerative diseases, including Alzheimer’s ...

(MMI) announced today that it received FDA investigational device exemption (IDE) to study its microsurgery platform.

Aqua Medical has received investigational device exemption (IDE) from the FDA for its ablation device aimed at treating ...